{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:21:39Z","timestamp":1787847699966,"version":"build-2784847793"},"reference-count":61,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Women receiving chemotherapy for breast cancer experience insomnia and fatigue, which impair quality of life. To date, no randomized clinical trial (RCT) has evaluated the use of cognitive behavior therapy for insomnia (CBT-I) and bright light therapy (BLT) both alone and in combination, and few have evaluated the use of either during chemotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the main effects of CBT-I and BLT on insomnia and fatigue symptoms in women undergoing chemotherapy for breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Sleep, Cancer, Rest (SleepCARE) was a 6-week, 2\u2009\u00d7\u20092 factorial, superiority, parallel RCT conducted at 5 metropolitan and regional hospitals in Australia from January 22, 2021, to August 21, 2024. Participants were women (aged \u226518 years) receiving chemotherapy for early or metastatic breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Two brief interventions were administered: CBT-I and BLT alone (using light glasses at 1500 lux) and in combination, creating 4 groups (CBT-I alone, BLT alone, CBT-I plus BLT, and sleep hygiene education [SHE]). All interventions included SHE. The interventions lasted 6 weeks and included a 1:1 consultation session, emails sent once or twice per week, and a midpoint call for all groups, as well as light glasses for the BLT groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Dual primary outcomes were Insomnia Severity Index (ISI) scores and Patient-Reported Outcomes Measurement Information System (PROMIS)\u2013Fatigue T scores. Both are patient-reported outcome measures and measure insomnia and fatigue symptoms, respectively. Assessments occurred via surveys administered at baseline and at the midpoint (3 weeks), postintervention (6 weeks), and follow-up (3 months and 6 months) periods. Modified intention-to-treat analyses used latent growth models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 219 women enrolled (mean [SD] age, 50.7 [10.8] years; 54 [26.9%] with metastatic cancer), 55 were randomized to CBT-I, 55 to BLT, 52 to CBT-I plus BLT, and 57 to SHE. A total of 208 women (95.0%) with any data at any time point were analyzed. Insomnia symptoms (ISI score mean difference [MD], \u22122.19 [95% CI, \u22123.33 to \u22121.05] points;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.002) but not fatigue symptoms (PROMIS-Fatigue score MD, \u22120.90 [95% CI, \u22123.08 to 1.28] points;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.52) improved more in the CBT-I groups compared with the non\u2013CBT-I groups. The BLT groups (compared with the non-BLT groups) did not differ in insomnia symptoms (ISI score MD, \u22120.88 [95% CI, \u22122.02 to 0.26] points;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.26) or fatigue symptoms (PROMIS-Fatigue score MD, \u22120.71 [95% CI, \u22122.89 to 1.47] points;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.52). Comparable results emerged in the high-adherence subgroup and in the subgroups with high initial insomnia and fatigue symptoms. However, exploratory subgroup analyses in women with metastatic breast cancer showed that BLT (vs non-BLT) improved insomnia symptoms (ISI score MD, \u22122.87 [95% CI, \u22125.06 to \u22120.67] points;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.01) and fatigue symptoms (PROMIS-Fatigue score MD, \u22125.16 [95% CI, \u22129.57 to \u22120.76] points;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In the SleepCARE RCT of CBT-I and BLT administered for 6 weeks to women receiving chemotherapy for breast cancer, CBT-I improved insomnia but not fatigue compared with SHE or BLT. BLT did not produce greater improvements in fatigue or insomnia symptoms compared with non-BLT treatment. The study findings indicate that brief CBT-I, but not BLT, may reduce insomnia symptoms among women receiving chemotherapy for breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ANZCTR Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=380470\">ACTRN12620001133921<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.30320","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:30:25Z","timestamp":1787844625000},"page":"e2630320","source":"Crossref","is-referenced-by-count":0,"title":["Cognitive Behavior vs Bright Light Therapy for Insomnia in Women Undergoing Chemotherapy for Breast Cancer"],"prefix":"10.1001","volume":"9","author":[{"given":"Trang Thuy","family":"Do","sequence":"first","affiliation":[{"name":"School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Maccora","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Wallace","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Aedo-Lopez","sequence":"additional","affiliation":[{"name":"Department of Oncology, Monash Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marliese","family":"Alexander","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Ancoli-Israel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California San Diego, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Bei","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Blum","sequence":"additional","affiliation":[{"name":"Department of Oncology, Bendigo Cancer Centre, Bendigo Health, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Boyle","sequence":"additional","affiliation":[{"name":"Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital North Sydney, Sydney, New South Wales, Australia"},{"name":"School of Medicine, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Day","sequence":"additional","affiliation":[{"name":"Department of Oncology, Monash Health, Melbourne, Victoria, Australia"},{"name":"Department of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Diggens","sequence":"additional","affiliation":[{"name":"People and Culture, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"},{"name":"Department of Psychology, Psychosocial Oncology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prudence A.","family":"Francis","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ftanou","sequence":"additional","affiliation":[{"name":"Department of Psychology, Psychosocial Oncology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila N.","family":"Garland","sequence":"additional","affiliation":[{"name":"Department of Psychology, Memorial University, St John\u2019s, Newfoundland and Labrador, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alysia","family":"Kepert","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Mortimer","sequence":"additional","affiliation":[{"name":"Centre for Health Economics, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J. K.","family":"Phillips","sequence":"additional","affiliation":[{"name":"Adelaide Institute for Sleep Health, Flinders Health and Medical Research Institute (Sleep Health), College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ballarat Regional Integrated Cancer Centre, Grampians Health, Ballarat, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Stafford","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"White","sequence":"additional","affiliation":[{"name":"Genomic Medicine and Parkville Familial Cancer Centre, The Royal Melbourne Hospital, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua F.","family":"Wiley","sequence":"additional","affiliation":[{"name":"School of Psychological Sciences, Monash University, Melbourne, Victoria, Australia"},{"name":"Department of Psychology, Psychosocial Oncology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"issue":"6","key":"zoi260827r1","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1177\/10547738221092146","article-title":"Prevalence of sleep disturbance in patients with cancer: a systematic review and meta-analysis.","volume":"31","author":"Al Maqbali","year":"2022","journal-title":"Clin Nurs Res"},{"issue":"2","key":"zoi260827r2","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1089\/jpm.2006.9.437","article-title":"Sleep disturbance in supportive care of cancer: a review.","volume":"9","author":"Kvale","year":"2006","journal-title":"J Palliat Med"},{"issue":"10","key":"zoi260827r3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","article-title":"Cancer-related fatigue\u2013mechanisms, risk factors, and treatments.","volume":"11","author":"Bower","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"zoi260827r4","doi-asserted-by":"publisher","first-page":"448","DOI":"10.6004\/jnccn.2008.0036","article-title":"Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy.","volume":"6","author":"Butt","year":"2008","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"zoi260827r5","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0885-3924(99)00082-2","article-title":"Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates.","volume":"18","author":"Jacobsen","year":"1999","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"zoi260827r6","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries.","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"issue":"5","key":"zoi260827r7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.sleh.2023.04.004","article-title":"Global prevalence of sleep disturbances among breast cancer survivors: a systematic review with meta-analysis.","volume":"9","author":"Cheng","year":"2023","journal-title":"Sleep Health"},{"issue":"1","key":"zoi260827r8","doi-asserted-by":"publisher","first-page":"12815","DOI":"10.1038\/s41598-023-39046-0","article-title":"Prevalence of cancer-related fatigue based on severity: a systematic review and meta-analysis.","volume":"13","author":"Kang","year":"2023","journal-title":"Sci Rep"},{"issue":"6","key":"zoi260827r9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/annonc\/mdw099","article-title":"Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors.","volume":"27","author":"Abrahams","year":"2016","journal-title":"Ann Oncol"},{"key":"zoi260827r10","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.817837","article-title":"Sleep during oncological treatment: a systematic review and meta-analysis of associations with treatment response, time to progression and survival.","volume":"16","author":"Str\u00f8m","year":"2022","journal-title":"Front Neurosci"},{"key":"zoi260827r11","first-page":"97","article-title":"Prognostic significance of baseline fatigue for overall survival: a patient-level meta-analysis of 43 oncology clinical trials with 3915 patients.","volume":"12","author":"Sloan","year":"2017","journal-title":"Trends Cancer Res"},{"issue":"2","key":"zoi260827r12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10549-006-9447-x","article-title":"Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients.","volume":"105","author":"Groenvold","year":"2007","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"zoi260827r13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13058-024-01822-9","article-title":"Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019.","volume":"26","author":"Bhimani","year":"2024","journal-title":"Breast Cancer Res"},{"issue":"10","key":"zoi260827r14","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1007\/s00520-013-1823-6","article-title":"A pan-Canadian practice guideline: prevention, screening, assessment, and treatment of sleep disturbances in adults with cancer.","volume":"21","author":"Howell","year":"2013","journal-title":"Support Care Cancer"},{"key":"zoi260827r15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.smrv.2015.07.001","article-title":"A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors.","volume":"27","author":"Johnson","year":"2016","journal-title":"Sleep Med Rev"},{"key":"zoi260827r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2020.101376","article-title":"Efficacy of cognitive behavioral therapy for insomnia in breast cancer: a meta-analysis.","volume":"55","author":"Ma","year":"2021","journal-title":"Sleep Med Rev"},{"issue":"3","key":"zoi260827r17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1080\/15402002.2011.634940","article-title":"Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer.","volume":"10","author":"Neikrug","year":"2012","journal-title":"Behav Sleep Med"},{"key":"zoi260827r18","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.815872","article-title":"Preventing sleep disruption with bright light therapy during chemotherapy for breast cancer: a phase II randomized controlled trial.","volume":"16","author":"Rissling","year":"2022","journal-title":"Front Neurosci"},{"issue":"5","key":"zoi260827r19","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1080\/07420528.2021.1871914","article-title":"Bright light shows promise in improving sleep, depression, and quality of life in women with breast cancer during chemotherapy: findings of a pilot study.","volume":"38","author":"Wu","year":"2021","journal-title":"Chronobiol Int"},{"issue":"1","key":"zoi260827r20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/gps.5412","article-title":"The therapeutic effects and safety of bright light therapy combined with escitalopram oxalate on insomnia in patients with poststroke depression.","volume":"36","author":"Xiao","year":"2021","journal-title":"Int J Geriatr Psychiatry"},{"issue":"6","key":"zoi260827r21","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s11136-012-0243-2","article-title":"Prevention of quality-of-life deterioration with light therapy is associated with changes in fatigue in women with breast cancer undergoing chemotherapy.","volume":"22","author":"Jeste","year":"2013","journal-title":"Qual Life Res"},{"issue":"6","key":"zoi260827r22","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00520-011-1203-z","article-title":"Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer.","volume":"20","author":"Ancoli-Israel","year":"2012","journal-title":"Support Care Cancer"},{"issue":"3","key":"zoi260827r23","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/zsab246","article-title":"Light enhanced cognitive behavioral therapy for insomnia and fatigue during chemotherapy for breast cancer: a randomized controlled trial.","volume":"45","author":"Bean","year":"2022","journal-title":"Sleep"},{"issue":"6","key":"zoi260827r24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00520-024-08554-8","article-title":"Telehealth cognitive behaviour therapy for the management of sleep disturbance in women with early breast cancer receiving chemotherapy: a feasibility study.","volume":"32","author":"Carson","year":"2024","journal-title":"Support Care Cancer"},{"issue":"106877","key":"zoi260827r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2022.106877","article-title":"The Sleep, Cancer and Rest (SleepCaRe) Trial: rationale and design of a randomized, controlled trial of cognitive behavioral and bright light therapy for insomnia and fatigue in women with breast cancer receiving chemotherapy.","volume":"120","author":"Maccora","year":"2022","journal-title":"Contemp Clin Trials"},{"issue":"22","key":"zoi260827r26","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2025.4347","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials.","volume":"333","author":"Hopewell","year":"2025","journal-title":"JAMA"},{"issue":"1","key":"zoi260827r27","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13063-018-2735-z","article-title":"CONSORT-SPI 2018 explanation and elaboration: guidance for reporting social and psychological intervention trials.","volume":"19","author":"Grant","year":"2018","journal-title":"Trials"},{"issue":"3","key":"zoi260827r28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7326\/M14-2841","article-title":"Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis.","volume":"163","author":"Trauer","year":"2015","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi260827r29","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkae041","article-title":"Interventions for insomnia in cancer patients and survivors-a comprehensive systematic review and meta-analysis.","volume":"8","author":"Nissen","year":"2024","journal-title":"J Natl Cancer Inst Cancer Spectr"},{"issue":"3","key":"zoi260827r30","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5664\/jcsm.7000","article-title":"Reliability of the Structured Clinical Interview for DSM-5 Sleep Disorders module.","volume":"14","author":"Taylor","year":"2018","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"zoi260827r32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the Insomnia Severity Index as an outcome measure for insomnia research.","volume":"2","author":"Bastien","year":"2001","journal-title":"Sleep Med"},{"issue":"2","key":"zoi260827r33","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"2","key":"zoi260827r34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0005-7916(00)00012-4","article-title":"Psychometric properties of the Credibility\/Expectancy Questionnaire.","volume":"31","author":"Devilly","year":"2000","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"3-4","key":"zoi260827r35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0149-7189(83)90011-3","article-title":"The role of client satisfaction in evaluating university counseling services.","volume":"6","author":"Greenfield","year":"1983","journal-title":"Eval Program Plann"},{"issue":"3","key":"zoi260827r36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0149-7189(82)90074-X","article-title":"The Client Satisfaction Questionnaire: psychometric properties and correlations with service utilization and psychotherapy outcome.","volume":"5","author":"Attkisson","year":"1982","journal-title":"Eval Program Plann"},{"key":"zoi260827r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2021.101531","article-title":"Structural validity of the Insomnia Severity Index: a systematic review and meta-analysis.","volume":"60","author":"Manzar","year":"2021","journal-title":"Sleep Med Rev"},{"issue":"6","key":"zoi260827r40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/pon.860","article-title":"Empirical validation of the Insomnia Severity Index in cancer patients.","volume":"14","author":"Savard","year":"2005","journal-title":"Psychooncology"},{"issue":"2","key":"zoi260827r41","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5664\/jcsm.8988","article-title":"Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.","volume":"17","author":"Edinger","year":"2021","journal-title":"J Clin Sleep Med"},{"issue":"11","key":"zoi260827r42","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008.","volume":"63","author":"Cella","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"zoi260827r43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jclinepi.2010.11.018","article-title":"Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients.","volume":"64","author":"Yost","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"zoi260827r46","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/10705511.2017.1402334","article-title":"MplusAutomation: an R package for facilitating large-scale latent variable analyses in Mplus.","volume":"25","author":"Hallquist","year":"2018","journal-title":"Struct Equ Modeling"},{"issue":"1","key":"zoi260827r47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"3","key":"zoi260827r48","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.0030-1299.2005.13727.x","article-title":"Implementing false discovery rate control: increasing your power.","volume":"108","author":"Verhoeven","year":"2005","journal-title":"Oikos"},{"key":"zoi260827r49","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e5840","article-title":"Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis.","volume":"345","author":"Kahan","year":"2012","journal-title":"BMJ"},{"issue":"12","key":"zoi260827r50","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-013096","article-title":"To condition or not condition? analysing \u2018change\u2019 in longitudinal randomised controlled trials.","volume":"6","author":"Coffman","year":"2016","journal-title":"BMJ Open"},{"key":"zoi260827r51","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.conctc.2018.03.008","article-title":"Different ways to estimate treatment effects in randomised controlled trials.","volume":"10","author":"Twisk","year":"2018","journal-title":"Contemp Clin Trials Commun"},{"issue":"3","key":"zoi260827r52","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1207\/S15328007SEM0803_5","article-title":"The relative performance of full information maximum likelihood estimation for missing data in structural equation models.","volume":"8","author":"Enders","year":"2001","journal-title":"Struct Equ Modeling"},{"issue":"10","key":"zoi260827r53","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1007\/s11136-014-0732-6","article-title":"Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment.","volume":"23","author":"Cella","year":"2014","journal-title":"Qual Life Res"},{"issue":"1","key":"zoi260827r54","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13063-020-4196-4","article-title":"Light-enhanced cognitive behavioural therapy for sleep and fatigue: study protocol for a randomised controlled trial during chemotherapy for breast cancer.","volume":"21","author":"Bean","year":"2020","journal-title":"Trials"},{"issue":"3","key":"zoi260827r55","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jebm.12485","article-title":"Cognitive behavior therapy for insomnia in cancer patients: a systematic review and network meta-analysis.","volume":"15","author":"Gao","year":"2022","journal-title":"J Evid Based Med"},{"issue":"10","key":"zoi260827r56","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1185\/03007990903167415","article-title":"Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference.","volume":"25","author":"Yang","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"13","key":"zoi260827r57","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1113\/jphysiol.2012.227892","article-title":"Human phase response curve to a 1 h pulse of bright white light.","volume":"590","author":"St Hilaire","year":"2012","journal-title":"J Physiol"},{"issue":"3","key":"zoi260827r58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001571","article-title":"Recommendations for daytime, evening, and nighttime indoor light exposure to best support physiology, sleep, and wakefulness in healthy adults.","volume":"20","author":"Brown","year":"2022","journal-title":"PLoS Biol"},{"issue":"9","key":"zoi260827r59","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s00520-015-2616-x","article-title":"Identification of distinct fatigue trajectories in patients with breast cancer undergoing adjuvant chemotherapy.","volume":"23","author":"Junghaenel","year":"2015","journal-title":"Support Care Cancer"},{"issue":"2","key":"zoi260827r60","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.cpr.2009.11.005","article-title":"A systematic review of therapeutic alliance, group cohesion, empathy, and goal consensus\/collaboration in psychotherapeutic interventions in cancer: uncommon factors?","volume":"30","author":"Schnur","year":"2010","journal-title":"Clin Psychol Rev"},{"issue":"3","key":"zoi260827r61","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/15402000701263932","article-title":"Patient expectations and therapeutic alliance as predictors of outcome in group cognitive-behavioral therapy for insomnia.","volume":"5","author":"Constantino","year":"2007","journal-title":"Behav Sleep Med"},{"key":"zoi260827r31","unstructured":"Kepert? A, Do? TT, Wiley? JF. SleepCARE consumer article and plain language summary. Open Science Framework. Updated July 30, 2026. Accessed July 30, 2026. https:\/\/osf.io\/msycd\/files\/jtnfy"},{"key":"zoi260827r37","unstructured":"Standard Australian Classification of Countries (SACC), 2016. Australian Bureau of Statistics. 2016. Accessed December 5, 2025. https:\/\/www.abs.gov.au\/statistics\/classifications\/standard-australian-classification-countries-sacc\/2016"},{"key":"zoi260827r38","unstructured":"Household income and wealth, Australia, 2019-20 financial year. Australian Bureau of Statistics. 2021. Accessed December 5, 2025. https:\/\/www.abs.gov.au\/statistics\/economy\/finance\/household-income-and-wealth-australia\/2019-20"},{"key":"zoi260827r44","unstructured":"Wiley? JF. Power analysis and statistical analysis code for SleepCare trial. Accessed December 5, 2025. https:\/\/github.com\/behavioralmedicinelab\/SleepCarePlanning"},{"key":"zoi260827r45","unstructured":"Wiley? JF, Wallace? R. The Sleep, Cancer and Rest (SleepCare) trial. Open Science Framework. Updated November 23, 2025. Accessed December 5, 2025. https:\/\/osf.io\/msycd\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2853358\/do_2026_oi_260827_1787237426.66671.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:30:28Z","timestamp":1787844628000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2853358"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.30320","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}